Micronized Dermal Matrix for Smile Lines: An Early Look

A 2026 trial from China compared an injectable made from finely ground, processed human skin tissue with an established collagen filler for deep smile lines, the folds that run from the nose to the corners of the mouth. At three and six months, the two products performed about the same, and the new material needed slightly less volume, though it caused more short-term swelling and soreness. This is early-stage research on a product that is not part of standard practice in Canada.

Why this was studied

Nasolabial folds, often called smile lines, deepen with age as the cheeks lose volume and support and the skin loses elasticity. They are one of the most common reasons people ask about filler. Today, hyaluronic acid filler is the most widely used option, partly because it can be dissolved if needed. Our article on nasolabial and marionette lines explains the usual approaches.

Researchers continue to look for materials that might last longer or encourage the skin to rebuild its own support. A micronized acellular dermal matrix is donated human skin that has been processed to remove the cells and then ground into tiny particles that can pass through a needle. The leftover protein scaffold is thought to act as a framework that the body's own cells can move into.

What the researchers did

The trial was run at five hospitals in China. Adults with moderate to severe smile lines were randomly assigned to receive either the dermal matrix product or a cross-linked collagen filler already approved by Chinese regulators. The study was double-blind, meaning neither the participants nor the evaluators knew which product had been used. People could have a top-up at six weeks if the correction was uneven or not enough.

Of 202 people who were randomized, 175 completed all follow-up visits. Evaluators scored the depth of the folds on a standard wrinkle scale at six weeks, three months and six months. Participants and injectors also rated overall improvement and satisfaction.

It is worth noticing that the comparison was with a collagen filler, not with the hyaluronic acid fillers most commonly used in Canada. That limits how directly the results apply to choices patients here usually face.

What they found

The main goal was to see whether the new product was "not worse" than the comparison, which is a common design when testing a new device. On that measure it succeeded:

• At three months, about 88% of the dermal matrix group and 85% of the collagen group had at least a one-grade improvement on both sides.
• At six months, the figures were about 71% and 70%, showing that both effects were fading for some people.
• The dermal matrix group used somewhat less product on average and needed fewer top-up injections.
• At six weeks, participants' own ratings of improvement and satisfaction actually favoured the collagen filler.

Firmness, redness and skin discolouration at injection sites were similar in both groups. Pain, swelling and warmth in the early days were noticeably more common with the dermal matrix, though these were mostly mild to moderate and settled within a week. No serious treatment-related problems were reported.

How strong is this evidence?

This is a reasonably sized randomized trial, which is a stronger design than many early studies of new fillers. Still, there are reasons for caution:

• Six months is short for a filler. It does not tell us how long results last or whether late reactions occur.
• The comparator is not the usual one in Canadian practice, so we do not know how the new material compares with hyaluronic acid filler.
• Some reported statistics in the published paper appear inconsistent, which readers and reviewers will want clarified.
• One population and one country were studied, so results may differ in other groups.
• No way to dissolve it. Unlike hyaluronic acid filler, a tissue-based product cannot be reversed with an enzyme if something goes wrong.

What it means for you

For now, this is research rather than an option to seek out. Micronized dermal matrix fillers are not part of standard aesthetic practice in Canada, and Health Canada authorization for any particular product may be limited or absent and can change. If you are curious about it, ask a physician whether it is authorized in Canada and appropriate for you. Please do not look for it from unregulated sources, travel clinics without clear oversight, or non-medical providers, especially given that it is made from donated human tissue.

If smile lines bother you, the first step is understanding why they look the way they do. Sometimes a better approach is to support the cheek rather than fill the fold itself. Sometimes skincare, skin-tightening treatments or simply accepting a natural feature is the right answer. Filler is not right for everyone, including people who are pregnant or breastfeeding, have an active skin infection near the area, or have certain autoimmune or bleeding conditions. Results vary from person to person.

Questions to ask at your consultation

• Is filler in the fold itself the right approach, or would supporting the cheek work better?
• Can the product you are recommending be dissolved if I am unhappy or there is a complication?
• How long do results usually last for someone like me?
• What side effects should I expect in the first week, and which signs mean I should call right away?

Frequently asked questions

Does needing less product mean it is better?

Not necessarily. Using less volume for a similar correction is interesting, but the overall results were equivalent, early discomfort was higher, and longer-term safety is unknown.

Is this the same as a collagen-stimulating filler?

Not quite. Collagen stimulators, such as poly-L-lactic acid (PLLA) and calcium hydroxylapatite, are synthetic materials that prompt the body to make collagen. A dermal matrix is processed human tissue that is meant to act as a scaffold. They are different materials with different evidence behind them.

Why does reversibility matter so much?

Filler complications are uncommon, but when a product blocks a blood vessel or sits in the wrong place, being able to dissolve it quickly is a major safety advantage. That is one reason many physicians prefer hyaluronic acid filler in delicate areas.

New filler materials are likely to keep appearing in research journals. If you would like a balanced look at what is available and appropriate for your smile lines, HealthPark Medical Aesthetics can talk it through with you at a consultation.

Source

Zhang C, Chang X, Chen L, et al. Safety and efficacy of micronized acellular dermal matrix injection for correction of moderate to severe nasolabial folds: a double-blind, multicenter, randomized controlled, non-inferior clinical trial. Aesthetic Plastic Surgery, 2026. Read the study